Serum @entity165 and XXXX : potential role in mortality prediction.

@entity1 @entity130 @entity1674 @entity412 @entity204 @entity165
The present study was performed in order to evaluate the diagnostic usefulness of serial @entity165 and @entity1674 measurements in @entity1 with severe burns. One of the main objective was to find out if these parameters are clinically relevant to determine the morbidity of a burn @entity1 and thereby the @entity1 's outcome. In 220 @entity1 with thermal injuries, @entity165 and @entity412 concentrations were measured daily. Blood samples were drawn immediately upon admission and thereafter daily until @entity1 's discharge or @entity204 . For both parameters, a characteristic course was noted: in the group of non-survivors, a decrease of @entity165 prior to @entity204 was noted, while survivors, increased prior to discharge. The time courses of both groups (survivors-non-survivors) differed statistically significantly (P=0.0068). An increase in @entity1674 was observed in all non-survivors prior to @entity204 , but in the group of survivors @entity1674 remained more or less unchanged. These time courses also had statistically significant differences (P=0.0004). In our 220 @entity1 , changes in @entity165 (P<0.0001, hazard ratio 1.02) and @entity1674 (P=0.0008, hazard ratio 1.01) had comparable capability to predict the severity of a burn @entity130 and thereby its outcome than the established parameters in the treatment of burns (total body surface area burned, age, inhalation). We consider the serial measurements of @entity165 and @entity1674 as clinically relevant to assess the morbidity of a @entity1 and thereby to estimate the @entity1 's outcome. We think that these serial measurements provide useful information for the clinician treating @entity1 with severe burns.
